STEALTH BIOTHERAPEUTICS CORP (MITO) Stock Balance Sheet
NASDAQ:MITO - Nasdaq - US85789A1051 - ADR - Currency: USD
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 33.83M | 47.13M | 32.79M | 50.77M | 10.86M | |||
| Other Current Assets | 2.57M | 2.47M | 2.26M | 1.63M | 2.44M | |||
| Total Current Assets | 36.40M | 49.60M | 35.04M | 52.40M | 13.29M | |||
| Non-Current Assets | ||||||||
| PPE Net | 88.00K | 97.00K | 110.00K | 350.00K | 500.00K | |||
| Other Non-Current Assets | 427.00K | 527.00K | 700.00K | 0.00 | 1.73M | |||
| Total Non-Current Assets | 515.00K | 624.00K | 810.00K | 340.00K | 2.23M | |||
| TOTAL ASSETS | 36.91M | 50.23M | 35.85M | 52.74M | 15.52M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 9.00M | 14.72M | 8.46M | |||
| Accrued Expenses | 5.77M | 7.36M | 8.52M | 9.71M | 21.12M | |||
| Accounts Payable | 4.12M | 3.47M | 3.53M | 9.52M | 11.02M | |||
| Total Current Liabilities | 9.89M | 10.83M | 21.05M | 33.95M | 40.61M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 13.78M | 13.66M | 0.00 | 1.53M | 113.57M | |||
| Other Non-Current Liabilities | 65.56M | 71.04M | 25.17M | 0.00 | 36.67M | |||
| Total Non-Current Liabilities | 79.34M | 84.69M | 25.17M | 1.53M | 150.24M | |||
| TOTAL LIABILITIES | 89.23M | 95.52M | 46.22M | 35.48M | 190.85M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | N/A | -607.98M | -555.45M | -498.00M | -426.27M | |||
| Additional Paid In Capital | N/A | 562.47M | 544.89M | 515.13M | 39.54M | |||
| Common Shares | N/A | 214.00K | 190.00K | 130.00K | 211.40M | |||
| Other Shareholders' Equity | -52.32M | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 73.74M | 73.21M | 65.29M | 42.49M | 42.49M | |||
| Tangible Book Value per Share | -0.07 | -0.06 | -0.02 | 0.04 | -0.94 | |||
| Total Shareholders' Equity | -52.32M | -45.30M | -10.37M | 17.27M | -175.33M | |||
| TOTAL LIABILITIES AND EQUITY | 36.91M | 50.23M | 35.85M | 52.74M | 15.52M | |||
| Statistics | ||||||||
| Debt/Equity | -0.26 | -0.30 | N/A | 0.09 | -0.65 | |||
| Current Ratio | 3.68 | 4.58 | 1.66 | 1.54 | 0.33 | |||
| Return On Assets (ROA) | -143.50% | -104.58% | -160.28% | -136.01% | -623.13% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -415.34% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21